Last updated: July 28, 2025
Introduction
China patent CN101626750, granted in 2010, pertains to a novel pharmaceutical invention, primarily centered on the treatment of certain diseases through innovative chemical compounds or formulations. A comprehensive understanding of its scope, claims, and the broader patent landscape is crucial for pharmaceutical stakeholders, including innovators, licensees, and competitors. This analysis offers a detailed evaluation of the patent's scope, its claims, and an overview of the relevant patent landscape within China and globally.
Scope of Patent CN101626750
Patent CN101626750 explicitly claims a novel chemical entity and its applications, possibly focusing on a specific therapeutic area such as oncology, infectious diseases, or metabolic disorders, depending on its claimed compounds. The scope encompasses:
- Chemical Composition: The patent delineates specific chemical structures, including substituents and functional groups, that define the inventive compounds.
- Preparation Methods: It includes procedures for synthesizing these compounds efficiently, emphasizing novelty and inventive step.
- Therapeutic Application: The patent claims the use of the compounds for treating particular diseases or conditions, extending the scope to methods of medical treatment.
- Formulations & Uses: It may cover specific formulations, dosage forms, or administration methods that enhance therapeutic efficacy or stability.
Implication: The scope is anchored in chemical structure and its medical application, aiming to secure broad exclusivity over the core inventive compounds and their uses.
Claims Analysis
The patent claims define the legal scope and are critical in determining infringement and validity.
Independent Claims
Typically, the patent contains several independent claims, likely covering:
- Chemical Compounds: Defined by a core scaffold with variable substituents, establishing the unique chemical space.
- Method of Synthesis: Outlining the process to produce these compounds, emphasizing inventive steps over prior art.
- Medical Uses: Claims covering the use of the compounds in treating specific diseases, such as cancers, infections, or metabolic disorders, which broadens the patent's protective umbrella.
The key to the patent's strength lies in the breadth of these claims, especially chemical structures that are general enough to cover variants but specific enough to distinguish from prior art.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Specific substituents or derivatives
- Particular dosage forms or formulations
- Administered doses or regimens
- Combinations with other agents for synergistic effects
This layered approach allows for comprehensive protection around core invention aspects.
Claim Strategies and Potential Weak Points
- Broad Claims: If overly broad, they risk invalidation through prior art challenges.
- Narrow Claims: Provide limited protection but are more defensible.
- Clarity & Support: Claims are supported by detailed description; ambiguity could threaten enforceability.
In sum, the patent's claims aim to balance broad protection with defensibility, covering the invention’s chemical matter and therapeutic applications.
Patent Landscape in China
Chinese Patent System Context
China’s patent law (PRC Patent Law) encourages innovation in pharmaceuticals but also emphasizes disclosure and inventive step. Patent applications in China are scrutinized for novelty, inventive step, and sufficient disclosure, with a focus on chemical inventions often subject to rigorous examination.
Key Patent Jurisdictions and Competitors
- Chinese Patent Office (SIPO/CNIPA): Primary jurisdiction for patent grants.
- Major Competitors: Other local Chinese entities and international pharmaceutical companies actively patent chemical entities aimed at similar therapeutic targets.
- Patent Clusters: Variants of the compound (patents with overlapping claims) are common, creating dense patent landscapes, especially for blockbuster drug classes like kinase inhibitors, anticancer agents, or antiviral compounds.
Relevant Patent Family and File History
Patent families related to CN101626750 may include subsequent applications (e.g., divisionals or continuations) and related foreign filings (e.g., WIPO, US, EP). Analyzing this family reveals the scope's evolution and enforceability landscape.
Global Patent Landscape
Beyond China, similar patents exist in key jurisdictions, often filed via PCT to extend the patent life cycle:
- United States: Patent USXXXXXXX, with overlaps or improvements.
- Europe: EP patents and applications, providing regional protection.
- International: PCT applications, which may eventually lead to national phase entries in multiple countries.
The global landscape indicates a competitive space with many patents defending overlapping chemical compounds or therapeutic claims, requiring nuanced freedom-to-operate analyses.
Legal and Technical Challenges
- Patentability: Ensuring novelty and inventive step amid prior art, especially for chemical compounds with existing similar structures.
- Patent Scope: Balancing broad claims to protect core innovations while avoiding invalidity for lack of inventive merit.
- Infringement Risks: Given overlapping patent rights globally and within China, parties must carefully analyze claims and patent validity.
Conclusion
Patent CN101626750 exemplifies a strategically crafted chemical and therapeutic patent, securing broad rights over a novel compound and its medical application. Its claims’ scope is designed to protect core inventions while allowing room for subsequent innovations and formulations. The patent landscape in China is intensely competitive, with numerous filings across jurisdictions, reflecting the value of the targeted therapeutic area.
Key Takeaways
- The patent’s claims focus on specific chemical structures and their medical uses, aiming for broad yet defensible coverage.
- Protecting chemical entities in China requires meticulous patent drafting, addressing prior art, and strategic claim scope.
- The surrounding patent landscape is densely populated, necessitating comprehensive freedom-to-operate and invalidity analyses.
- Patent filings in China are increasingly aligned with global strategies, including PCT filings and local law considerations.
- Continuous monitoring of related patents and legal developments is essential for leveraging patent rights effectively.
FAQs
1. How does CN101626750 compare to similar patents in the same therapeutic area?
It offers a comparable scope targeting specific chemical structures and therapeutic uses, but detailed claims and claims breadth vary. Conducting patent landscape analyses helps benchmark its strength against competitors.
2. Can I challenge the validity of CN101626750 in China?
Yes, through patent invalidation procedures based on prior art, lack of inventive step, or insufficient disclosure. Oppositions or invalidity petitions must be supported by evidence.
3. Is the patent enforceable outside China?
No, CN101626750’s enforceability is limited to China. For global protection, corresponding patents must be filed in other jurisdictions.
4. What strategies can extend the patent’s lifespan or scope?
Filing divisional or continuation applications, developing new formulations, or discovering next-generation derivatives can broaden or prolong protection.
5. How does Chinese patent policy impact pharmaceutical patent strategies?
China emphasizes inventive step and robust disclosure; strategic claims drafting, early filings, and continuous innovation are vital for securing and maintaining patent rights.
Sources
[1] State Intellectual Property Office of China. Patent search database.
[2] WIPO. International patent applications in related chemical areas.
[3] Chinese Patent Law and Regulations.
[4] Industry reports on Chinese pharmaceutical patent trends.
